Pathogen characteristics reveal novel antibacterial approaches for interstitial lung disease

Lu, Hai‐Wen; Ji, Xiao-Bin; Liang, Shuo; Fan, Lu; Bai, Jing; Chen, Ke-Bing; Zhou, Yin; Li, Huiping; Xu, Jin‐Fu

doi:10.1016/j.pupt.2014.03.005

Search citation statements

Order By: Relevance

Paper Sections

Select...

Identification and Susceptibility Testing1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

Publication Types

Select...

Article1

Book1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All S. aureus isolates were subjected to cefoxitin screening following the guidelines of the Clinical and Laboratory Standards Institute [9]. The isolates with a zone diameter of \19 mm were scored as methicillin resistant.…”

Section: Identification and Susceptibility Testingmentioning

confidence: 99%

Rapid Identification of Methicillin-Resistant Staphylococcus aureus (MRSA) by the Vitek MS Saramis system

Shan

Fang

et al. 2015

Curr Microbiol

View full text Add to dashboard Cite

A rapid, sensitive, and accurate Vitek MS assay was developed to distinguish clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from clinical isolates of methicillin-sensitive Staphylococcus aureus (MSSA) by developing an in-house knowledgebase of SuperSpectra. Three unique peaks, including peaks at 2305.6 and 3007.3 Da specific to MRSA, and 6816.7 Da specific to MSSA, were selected for differentiating MRSA and MSSA. This assay accurately identified 84 and 91% of clinical MRSA and MSSA strains out of the total 142 clinically acquired S. aureus strains that were tested. This method will greatly improve the efficiency of single clinical sample identification of MRSA, thereby facilitating a reduction in the transmission of MRSA in clinical settings.

show abstract

Section: Identification and Susceptibility Testingmentioning

confidence: 99%